From: miR-107 is involved in the regulation of NEDD9-mediated invasion and metastasis in breast cancer
Group | Number of cases | NEDD9 | χ2 | P value | |
---|---|---|---|---|---|
Low | High | ||||
Age (years) | Â | Â | Â | 0.033 | 0.984 |
 ≤ 40 | 18 | 10 | 8 |  |  |
 40 ~ 60 | 123 | 68 | 55 |  |  |
 ≥ 60 | 63 | 34 | 29 |  |  |
Grading of tumors | Â | Â | Â | 4.311 | 0.038 |
 I ~ II | 167 | 86 | 81 |  |  |
 III | 37 | 26 | 11 |  |  |
Tumor size (cm3) | Â | Â | Â | 2.059 | 0.151 |
 I ≤ 2 | 100 | 60 | 40 |  |  |
 I > 2 | 104 | 52 | 52 |  |  |
ER (Estrogen receptor) | Â | Â | Â | 11.16 | 0.001 |
 Negative | 95 | 64 | 31 |  |  |
 Positive | 107 | 48 | 61 |  |  |
PR (Progesterone receptor) | Â | Â | Â | 4.026 | 0.045 |
 Negative | 141 | 84 | 57 |  |  |
 Positive | 63 | 28 | 35 |  |  |
HER2 (Human epidermal growth factor receptor 2) | Â | Â | Â | 0.018 | 0.892 |
 Negative | 161 | 88 | 73 |  |  |
 Positive | 43 | 24 | 19 |  |  |
Ki67 | Â | Â | Â | 6.558 | 0.01 |
 Low | 100 | 64 | 36 |  |  |
 High | 104 | 48 | 56 |  |  |
Lymphatic metastasis | Â | Â | Â | 14.79 | 0.0001 |
 N0 | 133 | 60 | 73 |  |  |
 N1 + 2 + 3 | 71 | 52 | 19 |  |  |
TNM | Â | Â | Â | 4.791 | 0.091 |
 I | 55 | 22 | 33 |  |  |
 II | 107 | 60 | 47 |  |  |
 III | 42 | 30 | 12 |  |  |